Expanding nilotinib access in clinical trials (ENACT) study in adult patients with imatinib-resistant or -intolerant Philadelphia chromosome-positive (Ph+) chronic myelogenous leukaemia (CML) in chronic phase (CP), accelerated phase (AP), or blast crisis (BC): updated safety analysis

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Smith, G; Rizzieri, DA; Alimena, G; Al-Ali, H-K; Zaritskey, A; Shen, Z; Jootar, S; Hsu, Y; Veronese, ML; Nicolini, FE

Published Date

  • April 1, 2008

Published In

Volume / Issue

  • 141 /

Start / End Page

  • 34 - 35

Published By

Pages

  • 2

International Standard Serial Number (ISSN)

  • 0007-1048

Conference Name

  • 48th Annual Scientific Meeting of the British-Society-for-Haematology

Conference Location

  • Glasgow, SCOTLAND

Conference Start Date

  • April 7, 2008

Conference End Date

  • April 9, 2008